Agile Therapeutics
AGRX
#10274
Rank
โ‚ฌ9.09 M
Marketcap
1,32ย โ‚ฌ
Share price
0.00%
Change (1 day)
300.30%
Change (1 year)

EPS for Agile Therapeutics (AGRX)

EPS in 2024 (TTM): -3,58ย โ‚ฌ

According to Agile Therapeutics 's latest financial reports the company's current EPS (TTM) is -3,38ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -206,74ย โ‚ฌ an increase over its 2021 EPS that were of -1.361ย โ‚ฌ.

EPS history for Agile Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-3,58ย โ‚ฌ
2022-206,74ย โ‚ฌ-84.81%
2021-1.361ย โ‚ฌ30%
2020-1.047ย โ‚ฌ53.85%
2019-680,47ย โ‚ฌ-32.76%
2018-1.012ย โ‚ฌ
2016-1.762ย โ‚ฌ-26.28%
2015-2.390ย โ‚ฌ21.79%
2014-1.963ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
9,72ย โ‚ฌ-387.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1,19ย โ‚ฌ-135.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6,37ย โ‚ฌ-288.80%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
-0,04362ย โ‚ฌ-98.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
0,30ย โ‚ฌ-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA